[ET Net News Agency, 15 January 2025] CCB International raised the target price for
BeiGene (06160) to HKD179 from HKD173 and maintained the "outperform" rating.
The research house said it expects the US$442m operating loss in 2024 to turn to an
operating profit of US$88m in 2025F. (rc)